GlassScriptPhysician profile
John M Hubanks
NPI 1831354810
$10,903.65
in general payments reported to CMS, 2019-2025
32 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,939 · 2020: $216 · 2021: $1,149 · 2022: $1,807 · 2023: $806 · 2024: $897 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,724.41 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,093.87 | 2019-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $1,925.06 | 2019-2025 | Ams 700, Watchman Flx |
| Teleflex LLC | $1,049.39 | 2021-2023 | Urolift |
| Medtronic, INC. | $819.38 | 2021-2025 | Interstim, Altaviva |
| Abbvie INC. | $380.97 | 2019-2025 | |
| Astellas Pharma US INC | $352.08 | 2019-2023 | Xtandi |
| Pfizer INC. | $291.65 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $285.89 | 2023 | Prolaris |
| Janssen Biotech, INC. | $257.21 | 2019-2025 | Erleada |
| Storz Medical America, INC. | $143.45 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.61 | 2025 | |
| Procept Biorobotics Corporation | $138.93 | 2024-2025 | Aquabeam System |
| Blue Earth Diagnostics | $127.71 | 2019-2025 | Posluma |
| Calyxo, INC. | $116.31 | 2025 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $97.54 | 2023-2025 | Pylarify |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $82.11 | 2019-2024 | Provenge |
| Sumitomo Pharma America, INC. | $72.22 | 2023-2024 | Gemtesa, Orgovyx |
| Coloplast Corp | $64.71 | 2021-2024 | Speedicath |
| Axonics, INC. | $62.49 | 2021-2023 | Axonics, Bulkamid |
| Olympus America INC. | $59.26 | 2019-2023 | Itind System |
| Novartis Pharmaceuticals Corporation | $58.52 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $45.76 | 2023-2024 | Xiaflex, Aveed |
| Amgen INC. | $44.29 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $38.43 | 2020-2024 | |
| Accord Healthcare, INC. | $30.77 | 2024 | |
| Merck Sharp & Dohme LLC | $23.28 | 2024 | Keytruda |
| Hologic Sales and Service, LLC | $19.58 | 2024 | Aptima |
| Photocure INC | $18.79 | 2019 | |
| Urogen Pharma, INC. | $18.59 | 2021 | |
| Sun Pharmaceutical Industries INC. | $16.09 | 2020 | |
| Immunitybio, INC. | $14.70 | 2025 | |
| Neotract INC. | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.